| abstract |
(57) [Summary]nThe present invention relates to a novel human monoclonal antibody (mAb) and a gene encoding the monoclonal antibody. More specifically, the present invention relates to a human monoclonal antibody that specifically reacts with an epitope of the fusion (F) protein of the respiratory syncytial virus (RSV). Such antibodies are useful for the therapeutic and / or prophylactic treatment of RSV infection in human patients, especially infants and young children. |